Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
The influence of radiotherapy on the quality-of-life assessment of patients with breast cancer
 
More details
Hide details
1
Student Medical Faculty of the Medical University, Lublin, Poland Head of the Faculty: Prof. Teresa Małecka-Massalska PhD
 
2
Clinical Oncology Ward, St. John’s Cancer Centre, Lublin, Poland Head of the Ward: Prof. Elżbieta Starosławska MD, PhD
 
 
Submission date: 2022-06-07
 
 
Final revision date: 2022-08-11
 
 
Acceptance date: 2022-09-06
 
 
Publication date: 2022-09-30
 
 
Medical Studies 2022;38(3):205-209
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Breast cancer is a disease from which there is a high chance of recovery if it is detected early and proper therapeutic treatment is undertaken. Radiotherapy is one of the methods of local treatment of malignancies, using ionizing radiation. It is often the method of choice among women with breast cancer. Radiotherapy, like other methods of oncological treatment, can cause side effects that may reduce the patients’ quality of life.

Aim of the research:
The assessment of influence of radiotherapy on the quality of life of patients with breast cancer.

Material and methods:
The research method was a diagnostic survey, while the technique was a survey. The research tool was the author’s questionnaire. The EORTC QLQ-C30 questionnaire was used to measure the quality of life. The study included 88 women treated at the Oncology Department of the Centre of Oncology of the Lublin Region. The Fisher test and the c2 test were used in the statistical analysis.

Results and conclusions:
Patients treated with radiotherapy were satisfied with the effects of treatment. There were no differences in the assessment of the quality of life before and after radiotherapy treatment. In the studied group of patients, the overall severity of individual symptoms significantly affects the quality of life of women with breast cancer.
REFERENCES (19)
1.
Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Narodowy Instytut Onkologii – Instytut im. Marii Skłodowskiej-Curie- Państwowy Instytut Badawczy. http://onkologia.org.pl/raport... [Available at: 11.04.2022].
 
2.
Bińkowska M. Hormonalna terapia a nowotwory. In: Hormonalna terapia zastępcza. Skuba P (ed.). Wydawnictwo Lekarskie PZWL, Warsaw 2012; 348-370.
 
3.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
 
4.
Didkowska J, Wojciechowska U, Olasek P. Nowotwory złośliwe w Polsce w 2015 roku, Wyd. Centrum Onkologii – Instytut im. Marii Skłodowskiej Curie, Krajowy Rejestr Nowotworów, Warszawa 2017.
 
5.
Cancer Tomorrow. Estimated number of incident cases from 2018 to 2030, breast, females n.d. http://gco.iarc.fr/tomorrow/gr... e&apc_male=0&apc_female=0 (accessed August 16, 2019).
 
6.
Piątek J, Krauss H, Gaik M. Jakość życia kobiet po amputacji piersi. Przegl Ginekol Położ 2004; 4: 173-177.
 
7.
Jassem J, Krzakowski M, Breast cancer. Oncol Clin Pract 2018; 14: 171-215.
 
8.
Ławicki S, Mroczko B, Szmitkowski M. Markery nowotworowe raka piersi. Postęp Hig Med Dośw 2004: 58: 292-300.
 
9.
Genden EM, Ferlito A, Rinaldo A, Silver CE, Fagan JJ, Suárez C, Langendijk JA, Lefebvre JL, Bradley PJ, Leemans CR, Chen AY, Jose J, Wolf GT. Recent changes in the treatment of patients with advanced laryngeal cancer. Head Neck 2008; 30: 103-110.
 
10.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Mc Scarth H, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010; 11: 927-933.
 
11.
Straver ME, Meijnen P, van Tienhoven G, van de Vel- de CJH, Mansel RE, Bogaerts J, Demonty G, Duez N, Cataliot- ti L, Klinkenbijl J, Westenberg HA, van der Mijle H, Hurkmans C, Rutgers EJT. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 2010; 28: 731-737.
 
12.
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKin- non E, McGale P, McHugh T, Peto R, Taylor C, Wang Y. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-2106.
 
13.
Kalinowski P, Bojakowska U, Kowalska ME. Epidemiologia i analiza czynników ryzyka raka piersi. W drodze do brzegu życia. Praca zbiorowa. Uniwersytet Medyczny w Białymstoku 2013; 341-349.
 
14.
McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S. EBCTCG (Early Breast Cancer Trialists Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality ;meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014; 383: 2127-3135.
 
15.
Trybulec A, Georgiew F, Borowiec-Trybulec K. Ocena jakości życia pacjentek leczonych onkologicznie z powodu raka piersi. Health Prom Phys Activ 2019; 4: 14-20.
 
16.
Dziadziuszko R. Postawy radioterapii. In: Kompedium Chirurgii Onkologicznej. Jezierski A, Rutkowski P (eds.). Via Medica, Gdańsk 2014; 383-387.
 
17.
Stanisławek A, Rząca M. Kliniczne podstawy onkologii. In: Standardy, procedury w pielęgniarstwie onkologicznym. Łuczyk M, Szadowska-Szlachetka Z, Ślusarska B (eds). Wydawnictwo Lekarskie PZWL, Warszawa 2017; 22-23.
 
18.
Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology. Use of epoietin with cancer; evidence-based clinical practice guidelines of the American Society of Hematology. J Clin Oncol 2002; 20: 4083-4107.
 
19.
Chrobak M. Ocena jakości życia zależnej od stanu zdrowia. Probl Piel 2009; 17: 124-127.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top